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Infection of chicken cells with three Marek’s disease virus (MDV) serotypes interferes with expression of the major
histocompatibility complex (MHC or B complex) class I (BF) glycoproteins. BF surface expression is blocked after infection
of OU2 cells with MDV serotypes 1, 2, and 3. MDV-induced T-cell tumors suffer a nearly complete loss of cell surface BF upon
virus reactivation with 5-bromo-29-deoxyuridine (BUdR). The recombinant virus (RB1BUS2gfpD) transforming the MDCC-
UA04 cell line expresses green fluorescent protein (GFP) during the immediate early phase of viral gene expression. Of the
UA04 cells induced to express the immediate early GFP, approximately 60% have reduced levels of BF expression. All of the
reactivated UA04 and MSB1 tumor cells expressing the major early viral protein pp38 display reduced levels of BF. Thus, BF
down-regulation begins in the immediate early phase and is complete by the early phase of viral gene expression. The
intracellular pool of BF is not appreciably affected, indicating that the likely mechanism is a block in BF transport and not the
result of transcriptional or translational regulation. © 2001 Academic Press
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The evasion of acquired cellular immunity is critical for
infection and lifelong persistence of herpesviruses in
their hosts. The importance of cellular immunity is em-
phasized by the considerable number of viral proteins
herpesviruses use to alter the antigen-presenting ma-
chinery of the host cell. This interference with the major
histocompatibility complex (MHC) class I antigen-pre-
senting pathway is a common mechanism used by all
mammalian herpesviruses to evade immune detection
(Johnson and Hill, 1998). The herpes simplex viruses
(HSV-1 and -2) are a-herpesviruses that alter the trans-
ort of viral antigens into the endoplasmic reticulum (ER)
Hill et al., 1994; Hinkley et al., 1998; Jugovic et al., 1998).
HSV-1 encodes the immediate early protein ICP47 (US12)
which binds to the transporter proteins associated with
antigen presentation (TAP) (Galocha et al., 1997; Neu-
mann et al., 1997). The binding of ICP47 to the TAP1/
TAP2 complex inhibits the translocation of peptides from
the cytosol to the lumen of the ER. In the absence of
peptides in the ER, the nascent class I proteins fail to
mature into the trimolecular complex composed of pep-
tide, heavy chain, and b2-microglobulin. These naked
lass I proteins are degraded instead of being trans-
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198orted through the Golgi complex to the cell surface.
aricella zoster virus (VZV), pseudorabies virus (PRV),
nd bovine herpesvirus (BHV) are other a-herpesviruses
that reduce the cell surface expression of MHC class I in
infected cells (Cohen, 1998; Hariharan et al., 1993; Mel-
lencamp et al., 1991; Nataraj et al., 1997). VZV, PRV, and
BHV do not contain ICP47 homologues and the viral
proteins and mechanisms altering antigen presentation
have yet to be identified. Although the viral proteins
altering MHC expression are unknown, BHV was re-
cently shown to inhibit the peptide transport activity in
bovine cells (Hinkley et al., 1998). Thus, the peptide
transport mechanism appears to be a favorite target of
the a-herpesvirus family for altering antigen presentation
nd evading cell-mediated immunity.
The Marek’s disease virus (MDV) of chickens is the
nly known oncogenic a-herpesvirus inducing T-cell tu-
ors. Serotype I MDV is homologous both antigenically
nd molecularly to the nononcogenic serotype 2 and 3
iruses. All three serotypes are highly cell-associated
nd spread through cell-to-cell contact (Biggs, 1975). The
ell-associated nature of MDV suggests that the cellular
mmune response (CMI) is critical in controlling infection
nd tumor cell development (Omar and Schat, 1996; Pratt
t al., 1992) but conclusive in vivo evidence is lacking
(Schat, 1991). MDV is recognized by virus-specific cyto-
toxic T lymphocytes (CTL) (Omar et al., 1998; Pratt et al.,
1992); however, this response is weak compared with the
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199MDV INHIBITION OF BF SURFACE EXPRESSIONCTL response to other avian viruses (Fulton et al., 1995;
hacker et al., 1995; Uni et al., 1994). Interference with
he antigen-presenting machinery is one potential mech-
nism incapacitating the cell-mediated immune re-
ponse to MDV. Here we report on the ability of MDV to
own-regulate the surface expression of class I glyco-
roteins upon initial infection of chicken fibroblasts. A
imilar down-regulation of cell surface class I is ob-
erved after reactivation of latent MDV in T-cell tumor
ines. This down-regulation of class I is complete by the
ime the major early viral protein pp38 (Chen et al., 1992;
ui et al., 1990; Ui et al., 1998) is expressed. The intra-
ellular pool of class I heavy-chain proteins is not grossly
ffected, suggesting that the peptide transport mecha-
ism is a potential target.
RESULTS
orrelation of MDV infection and loss of cell surface
lass I
To investigate interactions between antigen presenta-
ion and MDV infection we used the OU2 chicken fibro-
last cell line, which expresses high levels of BF glyco-
roteins. The cells were infected with tissue culture
dapted stocks of serotypes 1, 2, and 3 to achieve rea-
onable levels of infection. The IAN86 monoclonal anti-
ody recognizes the gB glycoproteins of serotypes 1 and
and was used to determine the percentage of OU2
ells infected with the Md11 (serotype 1) and HVT (se-
otype 3) viruses. The Y5 monoclonal antibody recog-
izes a serotype 2 specific epitope (Silva and Lee, 1984)
nd was used to determine the percentage of OU2 cells
nfected in the SB1 (serotype 2) cultures. The results are
hown in Fig. 1A and quantitated in Table 1. Uninfected
FIG. 1. Down-regulation of cell surface class I on OU2 cells infected
infected with Md11, SB1, and HVT. Infected and control cells were ana
surface expression of MHC class I glycoproteins. The vertical bars indic
versus-uninfected (A) or down-regulated class I (B) presented in TableU2 cells have little or no background fluorescence
hen labeled with the virus-specific monoclonal antibod-
c
Ces. As expected, the three viral serotypes infect at much
ifferent levels. Serotype 3 (HVT) established an active
nfection in approximately 84% of the cells, while sero-
ype 2 (SB1) was detected in only 30% of the cells. The
ercentage of cells infected by the Md11 virus was 63%
nd is uncharacteristically high for a serotype 1 virus.
he Md11 stock used for this analysis was passed in
ulture more than 100 times, which may account for this
igh level of viral infection.
The class I expression of infected versus uninfected
ells was analyzed with the C6B12 monoclonal antibody
s shown in Fig. 1B. The uninfected OU2 cells express
igh levels of class I glycoproteins on their cell surface.
nfection with SB1, and to a lesser extent with the other
wo serotypes, produces two subpopulations of cells,
ne with reduced expression of cell surface class I
lycoproteins and a second with equal or enhanced
rotype 1, 2, and 3 MD viruses. (A) Flow cytometry analysis of OU2 cells
r expression of viral proteins. (B) Infected cells were analyzed for the
gate (fluorescent channel) used to determine the percentage infected
) Uninfected; (– z –) Md11; (. . .) SB1; (– –) HVT.
TABLE 1
Quantification of the Class I Down-Regulation in OU2 Cells Infected
with Serotypes 1, 2, and 3 MD Virus
Infecting virus
% virus-specific
mAb positivea
% with decreased
surface class Ia
No virus (control) 1 2
HVT (serotype 3) 84 88
SB1 (serotype 2) 30 28
Md11 (serotype 1) 63 68
a The percentage of cells positive for virus antigens and the
ercentage of cells displaying class I down-regulation were calcu-
ated based on the gates shown in Figs. 1A and 1B, respectively. The
onoclonal antibodies to virus-specific antigens were Y5 (serotype
) and IAN86 (serotypes 1 and 3, gB). The percentage of control (no
irus) cells falling in the positive range using the virus-specific
ntibodies was 1% or less. Less than 2% of the control (no virus)with se
lyzed foells were down-regulated for surface protein expression using the
6B12 antibody to chicken class I.
T repre
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200 HUNT ET AL.levels of class I compared with the uninfected control.
The mean channel fluorescence of the enhanced sub-
population in the SB1-infected cells is 4500 compared to
1200 mean channels of fluorescence in the uninfected
control cells. This represents a 3200 mean channel in-
crease of fluorescence in the SB1-infected cells com-
pared to the uninfected control cells. The reduced class
I subpopulation in the SB1 culture represents about 30%
of the total cells and is reduced about 40-fold compared
to the enhanced subpopulation. The HVT culture pro-
duces the most dramatic down-regulation of surface
class I with greater than 80% of the cells (see Table 1)
displaying 100- to 200-fold less class I than in the en-
hanced subpopulation. The enhanced subpopulation in
the serotype 1 Md11 cultures was not as dramatic as in
the other two serotypes. Approximately 70% of the cells
in the Md11 cultures displayed reduced levels of class I
expression. Compared with SB1, this represents a higher
percentage; however, the intensity of the class I expres-
sion is similar to its serotype 2 counterpart and not as
complete as in the HVT cultures. As shown in Table 1, the
percentages of cells expressing viral proteins correlates
with the percentage of cells displaying reduced levels of
class I glycoproteins.
Virus reactivation in MDV tumor cells induces class I
down-regulation
Treatment of the MDV-transformed MSB1 cells with
BUdR results in viral gene expression and virus produc-
tion presumably by reactivating the virus from the latent
state (Dunn and Nazerian, 1977). Figure 2 shows that the
treatment of MSB1 cells with BUdR specifically reduced
the surface expression of class I without grossly affect-
ing the expression of CD4 on the surface of MSB1 cells.
FIG. 2. Expression of CD4 and class I glycoproteins on the surface o
by BUdR in MSB1 cells. Quantification of cell surface CD4 (A) and clas
he dashed line represents a negative control antibody, the dotted line
ells cultured in 25 mg/ml of BUdR.In this experiment, 25.3% of the cells treated with 25
mg/ml BUdR had reduced levels of surface class I. In theabsence of BUdR the figure was 5.2% with reduced
levels of class I, indicating that 20.1% of the cells lost
class I upon culture with BUdR. In the same cultures only
6.5% of the cells had slightly reduced levels of the CD4
surface antigen. The histogram profiles in Fig. 2 clearly
show a distinct subpopulation of cells that have lost
class I expression that is not observed in the CD4 pro-
files.
Down-regulation of class I by MDV occurs in the
immediate early phase of gene expression
To determine the temporal nature of the class I down-
regulation three different cell lines were analyzed by
two-color flow cytometry for virus protein expression and
class I down-regulation after treatment with BUdR (Fig.
3). The Marek’s virus in the RP1 cell line is a nonproducer
or latent virus since treatment of the cells with BUdR
does not reactivate the transforming virus (Nazerian et
al., 1977). In this analysis the RP1 cells serve as a
negative control for the virus antigen-specific antibodies
used for the two-color labeling procedure and to show
that BUdR treatment alone does not grossly alter class I
surface expression. The GFP recombinant virus
RB1BUS2gfpD (serotype 1) was used to transform the
UA04 chicken T-cell line. The GFP in the UA04 cell line is
regulated as an immediate early gene by the recombi-
nant virus since the cytomegalovirus immediate early
promoter (CMVp) is used to drive GFP expression (Dien-
glewicz and Parcells, 1999). The expression of GFP in the
UA03 cells after virus reactivation with BUdR and is used
here as a marker for immediate early gene expression.
As noted above, the MSB1 cell line expresses the pp38
protein upon virus reactivation. The pp38 protein is used
as a marker for the early phase of virus gene expression
-treated MSB1 cells. Flow cytometry analysis of MD virus reactivation
ere analyzed in cultures containing 0 and 25 mg/ml of BUdR for 48 h.
sents cells cultured in 0 mg/ml of BUdR, and the solid line representsf BUdR
s I (B) w(Ui et al., 1998).
As expected, the virus in the RP1 cell line was not
G
U
201MDV INHIBITION OF BF SURFACE EXPRESSIONinduced to express the pp38 viral protein and the surface
expression of class I was not down-regulated (Fig. 3A).
Reactivation of the virus in MSB1 cells resulted in the
expression of pp38 and, as shown in Fig. 3B, nearly all of
the MSB1 cells expressing pp38 have down-regulated
FIG. 3. Two-color analysis of expressed virus proteins (pp38 and
FP) and cell surface class I glycoproteins. RP1 (A), MSB1 (B), and
A04 (C) were induced for 48 h with 10 mg/ml BUdR to reactivate the
transforming MD virus.their surface class I glycoproteins. In contrast, there is a
heterogeneity between the expression of GFP and cellsurface class I in the BUdR-treated UA04 cells (Fig. 3C).
Although 19% of the cells expressing the GFP have
down-regulated their class I glycoproteins, a significant
number of cells (11%) express both the GFP and normal
levels of cell surface class I (Table 2).
Intracellular class I protein is abundant in OU2 cells
with down-regulated surface class I
Serotype 3 (HVT) produces the most dramatic effects
on cell surface class I expression, presumably due to its
aggressive replication in vitro compared with serotypes
1 and 2. Therefore, lysates representing equal numbers
of uninfected and serotype 3 (HVT)-infected OU2 cells
were analyzed by immunoprecipitation for total class I
production. Approximately 80% of the infected cells used
for this analysis displayed down-regulated cell surface
class I as determined by flow cytometry. Figure 4 shows
the intracellular levels of the 42-kDa BF glycoproteins
determined by autoradiography (Plachy et al., 1992). Fig-
ure 4A indicates a 4-h exposure and densitometry of the
class I protein bands shows a 15% decrease (density 5
7576 for uninfected versus 6471 for infected cells for a
1.2-fold reduction) in the infected versus the uninfected
cells. Figure 4B indicates a 72-h exposure, showing the
background bands as a measure of total protein synthe-
sis in the infected and uninfected cells. As indicated by
densitometry of the background bands there is a 10%
average decrease (range 4 to 18%) in total protein pro-
duction in the infected versus uninfected cells. The 10%
decrease in total protein production in infected cells
does not account for the 100-fold (99%) reduction of
surface class I observed in the serotype 3-infected OU2
cells (Fig. 1B) and suggests a specific virus-induced
inhibition of class I expression.
DISCUSSION
We have shown that class I glycoproteins are severely
down-regulated on the surface of MDV-infected OU2
TABLE 2
Quantification of the Down-Regulation of Class I Glycoproteins
on the Surface of BUdR-Treated MSB1 Cells
BUdR
(mg/ml)
24 h 48 h
CD4 Class I CD4 Class I
0 0.0 2.9 1.0 5.2
10 0.1 5.5 5.8 21.0
25 0.1 6.9 7.5 25.3
Note. The effect of 24- and 48-h BUdR treatment on the levels of CD4
and class I expression in MSB1 cells. MSB1 cells were cultured in
media containing 0, 10, or 25 mg/ml of BUdR and analyzed for cell-
surface CD4 or class I glycoproteins. The percentage of cells with
reduced levels of each surface glycoprotein is presented based on the
histograms presented in Fig. 2.
202 HUNT ET AL.cells and in transformed tumor cells undergoing reacti-
vation of latent virus. When uninfected, the OU2 fibro-
blast cells express large quantities of class I on their cell
surface, displaying over 1000 channels of fluorescence
using the C6B12 monoclonal antibody. In contrast, cell
surface expression of class I on serotype 3-infected OU2
cells is reduced 100-fold to 10 channels of fluorescence.
Our results indicate that this effect is not due to an
overall shutdown of host protein synthesis since cell
surface CD4 is nearly normal after virus reactivation in
MDV-induced tumor cells. Further, the total (intracellular
and cell surface) levels of class I glycoprotein are only
slightly lower (;15% or 1.2-fold reduction) in the HVT-
infected versus control OU2 cells. This suggests that
neither transcriptional nor translational inhibition is the
primary factor in this down-regulation of cell surface
class I.
In HSV, the ICP47 (US12) protein is instrumental in
class I down-regulation. The ICP47 protein interacts with
the transporter proteins and prevents cytosolic peptides
from binding to the TAP1/TAP2 complex (Jugovic et al.,
1998). The genomic structure of MDV is similar to HSV;
however, the unique short (US) region of serotype I MDV
does not encode a HSV US12 (ICP47) homologue
(Brunovskis and Velicer, 1995). The unique short region
of human cytomegalovirus (HCMV) contains at least four
FIG. 4. Immunoprecipitation of MHC class I from uninfected and
serotype 3-infected OU2 cells. Infected and uninfected cells (105 cell
equivalents of each) were analyzed by immunoprecipitation using the
C6B12 monoclonal antibody to MHC class I. The total amount of class
I protein is similar in infected and uninfected cells. (A) 4-h exposure
showing the density of the class I protein band in the infected and
uninfected cells (density 5 7576 for uninfected, 6471 for infected). (B)
72-h exposure showing a slight decrease in total protein synthesis as
indicated by the background bands in the infected versus uninfected
cells (10% average decrease with a range of 4 to 18%). The arrows on
the right indicate the position of the protein size markers (kDa).genes (US2, US3, US6, and US11) that are instrumental in
down regulating peptide transport and cell surface ex-pression of class I (Ahn et al., 1997; Machold et al., 1997;
Wiertz et al., 1996). Early in infection, US3 retains class I
in the ER while US2 and US11 reroute class I heavy
chains to the cytosol for degradation. The US6 glycopro-
tein inhibits translocation of peptides by binding TAP in
the lumen of the ER (Ahn et al., 1997). As with ICP47,
homologues of the HCMV US regions are not present in
the US region of serotype I MDV. Thus, the MDV gene
product or products responsible for class I down-regu-
lation are likely to be unique.
Although the MDV gene products down-regulating
class I appear unique, the general mechanisms are likely
to resemble HSV. Like ICP47, the MDV proteins affecting
class I expression appear to be expressed in the imme-
diate early phase of viral replication, the amount of in-
tracellular class I protein does not appear to be grossly
affected, and enhanced degradation of the heavy chain
is not observed in the cell lines used for this analysis.
Therefore peptide transport or retention of class I in the
ER is a probable target altering class I surface expres-
sion in active MDV infections (Jugovic et al., 1998).
The ability of MDV to alter antigen presentation is
likely to play a role in the pathogenesis of the virus in vivo
and helps explain various in vitro observations. All three
serotypes, including vaccine strains (HVT and SB1), have
the capacity to down-regulate cell surface class I and
evade cellular immunity. Evasion of cellular immunity is
likely to play a key role in the lifelong persistence dem-
onstrated by all three serotypes. The expression of pp38,
the major virus early antigen, is consistently observed in
vivo but recognized only weakly by the host’s cellular
immune system (Baigent et al., 1998, 1996; Omar and
Schat, 1996; Omar et al., 1998). Down-regulation of cell
surface class I before pp38-expression may help to ex-
plain how pp38 positive tumor cells escape immune
detection and the weak nature of the CTL activity to this
major virus antigen. The loss of cell surface class I is a
signal to activate killing by NK cells and may contribute
to the robust natural killer activity observed after MDV
infection (Lessard et al., 1996; Quere and Dambrine,
1988; Sharma, 1981).
Infection with all three serotypes induces a subpopu-
lation of presumably uninfected OU2 cells to express
increased levels of surface class I. This is may be due to
the induction of interferon or other cytokines that then
up-regulate class I expression on the uninfected popu-
lation. Importantly, there is heterogeneity among the se-
rotypes used in this study with regard to this activity. The
SB1 virus, a common strain used to complement HVT in
bivalent vaccines, induces a high level of class I expres-
sion in this subpopulation. Induction of cytokines like
interferon may be important since they are known to
partially overcome loss of antigen presentation in her-
pesvirus-infected tumor cells (Rowe et al., 1995). Testing
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203MDV INHIBITION OF BF SURFACE EXPRESSIONand optimizing this activity may be important for future
vaccine design.
We are attempting to identify the viral gene(s) encod-
ing the protein(s) involved in down-regulating the cell
surface class I. In HSV and CMV, the US regions contain
many of the viral genes affecting antigen presentation.
The series of recombinant RB1B Marek’s viruses with
deletions in MDV specific open reading frames (SORF) 1,
2, 3 and US1, 2, 3, 6, and 10 will be helpful in identifying
genetic regions of importance in this regard (Parcells et
al., 1994a, b, 1995). Once identified, recombinants lack-
ing these viral genes can be produced and their biologic
function tested in vitro and in vivo. Recombinant viruses
acking the ability to down-regulate class I may have
ecreased virulence and improved vaccine efficacy.
MATERIALS AND METHODS
ells and viruses
Virus stocks of HVT (serotype 3) (Okazaki et al., 1970),
nd SB1 (serotype 2) (Schat and Calnek, 1978) were
ropagated in chick embryo fibroblasts (CEFs) (Witter et
l., 1970). The Md11 (serotype 1) was propagated on
uck embryo fibroblasts (DEFs) as described (Witter,
982). The viruses used were highly tissue culture
dapted with over 50 passages in vitro.
CHCC-OU2 (OU2) cells are a chemically transformed,
irus-free chick embryo fibroblast isolated from chickens
f unknown B haplotype (Ogura and Fujiwara, 1987).
low cytometric analysis of this cell line identified the
13 haplotype and an unknown haplotype similar, but not
dentical, to B21 (data not shown, for details see Fulton et
l., 1996). The MDCC-MSB1 (MSB1) (Akiyama and Kato,
974), MDCC-UA04 (Dienglewicz and Parcells, 1999), and
P1 (Nazerian et al., 1977) cells are MDV-transformed
-cell lines. The MSB1 (B haplotype unknown) and RP1
B2/15) are T-cell lines transformed with the BC-1 and JM
trains of MDV, respectively (Nazerian et al., 1977; Naz-
rian and Witter, 1975). UA04 (B haplotype unknown) is a
-cell line transformed by a green fluorescent protein
GFP) recombinant of the RB1B strain of serotype 1 MDV
RB1BUS2gfpD) (Dienglewicz and Parcells, 1999). The
atent virus in MSB1 and UA04 can be reactivated upon
reatment with BUdR (Dunn and Nazerian, 1977). Con-
ersely, the JM virus transforming the RP1 cells is refrac-
ory to reactivation and is considered a nonproducer cell
ine (Nazerian et al., 1977). All cells were grown in Lei-
ovitz-McCoy medium supplemented with antibiotics, 5%
etal bovine serum (FBS), and 12% tryptose phosphate
roth (GIBCO, Grand Island, NY).
To induce virus reactivation, the MDV tumor cells were
ultured in 10 or 25 mg/ml BUdR (Sigma, St. Louis, MO)
for 24 and 48 h. Fresh media containing BUdR was used
6to maintain cell densities at approximately 1–10 3 10
cells per milliliter for the 48-h culture period. bThe OU2 cells were initially infected with approxi-
mately 500 plaque-forming units of each virus stock. All
serotypes of MDV are highly cell-associated, spread by
cell-to-cell contact, and produce little or no cell-free vi-
rus. Initial infection ranges from approximately 20% with
serotype 3 to 5% with serotypes 1 and 2. To achieve a
high percentage of cells infected with each serotype, the
infected OU2 cells were passaged two to four times on
subconfluent cultures of OU2 cells until the plaques for
each serotype culture were greater than approximately
10 per microscope field (253 magnification). The OU2
cells were then harvested using 0.5% trypsin (GIBCO) in
PBS/EDTA (0.5 mM EDTA), washed with PBS, and sub-
sequently analyzed for class I and viral protein expres-
sion.
Antibodies and reagents
The chicken class I glycoproteins (BF) were detected
by flow cytometry and immunoprecipitation using the
C6B12 monoclonal antibody (Shamansky et al., 1988).
The MDV antigens were detected using the H19 (sero-
type 1, anti-pp38), Y5 (serotype 2), and IAN86 (serotypes
1 and 3, gB) monoclonal antibodies (Cui et al., 1990; Silva
and Lee, 1984). Chicken CD4 was detected using the
CT-4 monoclonal antibody (Chan et al., 1988) (Southern
Biotechnology Associates, Birmingham, AL). The sec-
ondary reagents used to detect the monoclonal antibod-
ies include fluorescein-conjugated goat anti-mouse, bi-
otin-conjugated goat anti-mouse, PE-CY5-conjugated
avidin, and horseradish peroxidase-conjugated goat
anti-mouse. All of the secondary reagents were pur-
chased from Southern Biotechnology Associates or
Kirkegaard Perry Laboratory, Inc. (Gaithersburg, MD),
and used as described by the manufacturer.
Flow cytometry
Cells were washed and resuspended in cold flow
cytometry media (FCM) consisting of phosphate-buffered
saline (PBS) supplemented with 2% FBS and 0.1% NaN3.
ingle-color surface labeling of cells for the BF, CD4, and
B antigens was done by incubating 2–5 3 106 cells with
the appropriate dilution (determined by titration) of pri-
mary monoclonal antibody for 20 min on ice. The excess
primary antibody was removed by three successive
washes with ice-cold FCM followed by incubation of the
cells for an additional 20 min with the secondary anti-
body reagent. The secondary antibody consisted of ei-
ther fluorescein- or biotin-conjugated goat anti-mouse
antibody. The excess secondary antibody was removed
by three additional washes. To label the biotin-conju-
gated antibodies, the cells were incubated for 10 min
with PE-CY5-conjugated avidin (1:50). The cells were
4then washed as above and 1 3 10 cells were analyzed
y flow cytometry using a Becton–Dickinson FACSort,
BB
C
C
D
D
F
F
G
H
H
H
204 HUNT ET AL.(Becton–Dickinson Immunocytometry Division, San Jose,
CA).
For dual-color analysis of class I and internal viral
proteins, the cells were first labeled for BF using the
single-color fluorescein procedure described above. The
cells were then fixed with 4% (w/v) paraformaldehyde
(Sigma) in PBS (pH 7.4–7.6) for 20 min, washed in FCM
buffer, and permeabilized with 0.1% (w/v) saponin
(Sigma) in FCM (permeabilization buffer). The succeed-
ing steps, including antibody dilutions, were carried out
in permeabilization buffer. To label intracellular pp38, the
cells were incubated with the H19 mAb for 20 min,
washed, and incubated for an additional 20 min with
biotin-conjugated goat anti-mouse. The cells were again
washed and incubated for 10 min with PE-CY5-conju-
gated avidin. The cells were then washed extensively
and analyzed by flow cytometry. Controls included cells
incubated with equal concentrations (as determined by
OD280) of an isotype control mAb (M1, Kodak, Rochester,
NY) and stained as described for pp38. To adjust the
FACSort for two-color acquisition fixed but unlabeled,
surface label only and intracellular label only was used
in addition to the controls listed above.
The UA04 cells express GFP as a marker for viral
protein expression and dual labeling simply consisted of
developing the C6B12 (class I) antibody with the biotin-
conjugated goat anti-mouse and PE-CY5-conjugated avi-
din using viable, unfixed cells. Controls to adjust the
FACSort consisted of UA04 and UA04 plus an isotype
control (M1 see above) labeled with the biotin-conju-
gated goat anti-mouse/PE-CY5-conjugated avidin sys-
tem.
Immunoprecipitation
Uninfected and HVT-infected OU2 cells were radiola-
beled in methionine-free medium (MEM plus 1% dialyzed
FBS) containing 50 mCi of [35S]methionine/ml for 4 h at
37°C. Radiolabeled cells were lysed in RIPA buffer (150
mM NaCl, 50 mM Tris–HCl [pH 7.4], 1% DOC, 0.1% SDS,
and 1% Triton X-100) and the cell lysates preadsorbed to
protein A sepharose (Pharmacia, Uppsala, Sweden) for
30 min at 4°C. Preadsorbed cell lysates were then incu-
bated with monoclonal antibody to MHC Class I (C6B12)
for 1 h at 4°C and then with protein A sepharose for 1 h
at 4°C. Immune complexes were then washed three
times with RIPA buffer, separated on a 9% SDS–PAGE gel
(Laemmli, 1975), and proteins visualized by autoradiog-
raphy. The density of the bands in the autoradiographs
were analyzed using the program NIH Image (Version
1.61) according to the program instructions for gel anal-
ysis (http://rsb.info.nih.gov/nih-image).
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